Laurence H Patterson Selected Research

Laurence H Patterson Research Topics

Disease

28	Neoplasms (Cancer) 08/2023 - 08/2002
5	Hypoxia (Hypoxemia) 01/2023 - 08/2002
5	Neoplasm Metastasis (Metastasis) 07/2020 - 10/2012
3	Prostatic Neoplasms (Prostate Cancer) 11/2017 - 10/2012
3	Ovarian Neoplasms (Ovarian Cancer) 10/2005 - 07/2003
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 05/2017
2	Breast Neoplasms (Breast Cancer) 01/2017 - 11/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2013 - 01/2013
1	Bradycardia 01/2022
1	Squamous Cell Carcinoma of Head and Neck 05/2017
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Osteoporosis 08/2014
1	Thrombosis (Thrombus) 08/2014
1	Colonic Neoplasms (Colon Cancer) 06/2013
1	Neuroblastoma 01/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2013
1	Transitional Cell Carcinoma 01/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2013
1	Adenocarcinoma 10/2012
1	Disease Progression 11/2011
1	Necrosis 09/2010
1	Osteosarcoma (Osteogenic Sarcoma) 10/2005
1	Turcot syndrome 01/2005

Drug/Important Bio-Agent (IBA)

7	ProdrugsIBA 01/2023 - 01/2010
5	polysialic acidIBA 05/2021 - 01/2013
4	IntegrinsIBA 08/2023 - 10/2012
4	DuocarmycinsIBA 01/2021 - 01/2013
4	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 01/2013
4	DNA (Deoxyribonucleic Acid)IBA 06/2012 - 01/2005
3	OCT1002IBA 01/2023 - 04/2017
3	AQ4NIBA 01/2023 - 08/2002
3	EnzymesIBA 01/2021 - 06/2013
3	Cytotoxins (Cytolysins)IBA 01/2016 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 10/2005 - 07/2003
2	Protein Isoforms (Isoforms)IBA 01/2021 - 08/2002
2	ICT 2552IBA 01/2016 - 09/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 09/2010
2	ICT2588IBA 04/2014 - 09/2010
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 08/2013 - 01/2013
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 07/2013 - 01/2013
2	ChemokinesIBA 01/2013 - 11/2011
2	AlchemixIBA 06/2012 - 07/2003
2	OxidesIBA 11/2006 - 08/2002
2	AnthraquinonesIBA 10/2005 - 07/2003
1	arginyl-glycyl-aspartic acidIBA 08/2023
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2023
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2022
1	endo-alpha-sialidaseIBA 05/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 05/2021
1	Polysaccharides (Glycans)IBA 05/2021
1	CarcinogensIBA 01/2021
1	hydroxide ionIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2019
1	CyclodextrinsIBA 10/2019
1	1- cyclohexyl- 2- (5H- imidazo(5,1- a)isoindol- 5- yl)ethanolIBA 10/2019
1	Docetaxel (Taxotere)FDA Link 11/2017
1	abirateroneIBA 11/2017
1	cabazitaxel FDA Link 11/2017
1	Arginine (L-Arginine)FDA Link 05/2017
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 05/2017
1	Aspartic Acid (Aspartate)FDA Link 05/2017
1	bicalutamide (Casodex)FDA LinkGeneric 04/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Milk Proteins (Milk Protein)IBA 01/2017
1	CarbohydratesIBA 10/2016
1	GlycosyltransferasesIBA 10/2016
1	PolymersIBA 10/2016
1	Peptides (Polypeptides)IBA 04/2014
1	von Willebrand FactorIBA 04/2014
1	Indicators and Reagents (Reagents)IBA 04/2014
1	cyclopropapyrroloindoleIBA 08/2013
1	(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)(5- fluoro- 1H- indol- 2- yl)methanoneIBA 06/2013
1	(5- chloro- 1H- indol- 2- yl)(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)methanoneIBA 06/2013
1	Histones (Histone)IBA 06/2013
1	Mixed Function Oxygenases (Monooxygenases)IBA 06/2013
1	(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)(5- methoxy- 1H- indol- 2- yl)methanoneIBA 01/2013
1	Chemokine ReceptorsIBA 01/2013
1	Chemokine CXCL12IBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 11/2011
1	Membrane-Associated Matrix MetalloproteinasesIBA 09/2010
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 09/2010
1	Oxygen (Dioxygen)IBA 09/2010
1	Hormones (Hormone)IBA 01/2010
1	Adenosine Triphosphate (ATP)IBA 01/2007
1	A-Form DNA (A-DNA)IBA 10/2005
1	Topoisomerase II InhibitorsIBA 10/2005
1	AntimetabolitesIBA 01/2005
1	Alkylating AgentsIBA 01/2005
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2005
1	CamptothecinIBA 01/2005
1	AnthracyclinesIBA 07/2003
1	Cytochrome P-450 CYP3AIBA 01/2003
1	Complementary DNA (cDNA)IBA 01/2003

Therapy/Procedure

5	Therapeutics 08/2023 - 10/2012
4	Drug Therapy (Chemotherapy) 06/2013 - 08/2002
1	Immunotherapy 10/2019